These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22806998)

  • 21. Investigation of saturation and photobleaching of allophycocyanin by single-molecule recrossing events.
    Tian Y; Pappas D
    Appl Spectrosc; 2010 Mar; 64(3):324-7. PubMed ID: 20223069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitive fluorescence polarization technique for rapid screening of alpha-synuclein oligomerization/fibrillization inhibitors.
    Luk KC; Hyde EG; Trojanowski JQ; Lee VM
    Biochemistry; 2007 Nov; 46(44):12522-9. PubMed ID: 17927212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measuring, in solution, multiple-fluorophore labeling by combining fluorescence correlation spectroscopy and photobleaching.
    Delon A; Wang I; Lambert E; Mache S; Mache R; Derouard J; Motto-Ros V; Galland R
    J Phys Chem B; 2010 Mar; 114(8):2988-96. PubMed ID: 20143802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site-Specific Three-Color Labeling of α-Synuclein via Conjugation to Uniquely Reactive Cysteines during Assembly by Native Chemical Ligation.
    Lee TC; Moran CR; Cistrone PA; Dawson PE; Deniz AA
    Cell Chem Biol; 2018 Jun; 25(6):797-801.e4. PubMed ID: 29681525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of DNA aptamers that recognize α-synuclein oligomers using a competitive screening method.
    Tsukakoshi K; Abe K; Sode K; Ikebukuro K
    Anal Chem; 2012 Jul; 84(13):5542-7. PubMed ID: 22697251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coumarin 6 and 1,6-diphenyl-1,3,5-hexatriene (DPH) as fluorescent probes to monitor protein aggregation.
    Makwana PK; Jethva PN; Roy I
    Analyst; 2011 May; 136(10):2161-7. PubMed ID: 21445407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural properties of pore-forming oligomers of alpha-synuclein.
    Kim HY; Cho MK; Kumar A; Maier E; Siebenhaar C; Becker S; Fernandez CO; Lashuel HA; Benz R; Lange A; Zweckstetter M
    J Am Chem Soc; 2009 Dec; 131(47):17482-9. PubMed ID: 19888725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins.
    Schnack C; Danzer KM; Hengerer B; Gillardon F
    Neuroscience; 2008 Jul; 154(4):1450-7. PubMed ID: 18541383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome.
    Emmanouilidou E; Stefanis L; Vekrellis K
    Neurobiol Aging; 2010 Jun; 31(6):953-68. PubMed ID: 18715677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Membrane-bound structure and energetics of alpha-synuclein.
    Mihajlovic M; Lazaridis T
    Proteins; 2008 Feb; 70(3):761-78. PubMed ID: 17729279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells.
    Yamakawa K; Izumi Y; Takeuchi H; Yamamoto N; Kume T; Akaike A; Takahashi R; Shimohama S; Sawada H
    Biochem Biophys Res Commun; 2010 Jan; 391(1):129-34. PubMed ID: 19900407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-molecule fluorescence studies of intrinsically disordered proteins.
    Ferreon AC; Moran CR; Gambin Y; Deniz AA
    Methods Enzymol; 2010; 472():179-204. PubMed ID: 20580965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiparallel arrangement of the helices of vesicle-bound alpha-synuclein.
    Drescher M; Veldhuis G; van Rooijen BD; Milikisyants S; Subramaniam V; Huber M
    J Am Chem Soc; 2008 Jun; 130(25):7796-7. PubMed ID: 18512917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescence lifetime measurements of intrinsically unstructured proteins: application to α-synuclein.
    Schreurs S; Kluba M; Meuvis J; Engelborghs Y
    Methods Mol Biol; 2012; 895():461-6. PubMed ID: 22760334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of inhibitor-bound alpha-synuclein dimer: role of alpha-synuclein N-terminal region in dimerization and inhibitor binding.
    Yamaguchi Y; Masuda M; Sasakawa H; Nonaka T; Hanashima S; Hisanaga S; Kato K; Hasegawa M
    J Mol Biol; 2010 Jan; 395(3):445-56. PubMed ID: 19895818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The behavior of alpha-synuclein in neurons.
    Fortin DL; Nemani VM; Nakamura K; Edwards RH
    Mov Disord; 2010; 25 Suppl 1():S21-6. PubMed ID: 20187244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy.
    Apetri MM; Maiti NC; Zagorski MG; Carey PR; Anderson VE
    J Mol Biol; 2006 Jan; 355(1):63-71. PubMed ID: 16303137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation.
    Leong SL; Pham CL; Galatis D; Fodero-Tavoletti MT; Perez K; Hill AF; Masters CL; Ali FE; Barnham KJ; Cappai R
    Free Radic Biol Med; 2009 May; 46(10):1328-37. PubMed ID: 19248830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 11-mer repeats of human alpha-synuclein in vesicle interactions and lipid composition discrimination: a cooperative role.
    Bisaglia M; Schievano E; Caporale A; Peggion E; Mammi S
    Biopolymers; 2006; 84(3):310-6. PubMed ID: 16411187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The aggregation and fibrillation of alpha-synuclein.
    Fink AL
    Acc Chem Res; 2006 Sep; 39(9):628-34. PubMed ID: 16981679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.